Aberdeen Asset Management’s Edwards Lifesciences EW Stock Holding History

Aberdeen Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$7.33M	Sell	186,024 -10,857	-6%	-$396K	0.02%	407
2017 Q1	$6.17M	Sell	196,881 -132,351	-40%	-$4.14M	0.02%	425
2016 Q4	$10.3M	Sell	329,232 -319,941	-49%	-$10.4M	0.04%	323
2016 Q3	$26.1M	Sell	649,173 -227,805	-26%	-$8.58M	0.09%	176
2016 Q2	$29.2M	Sell	876,978 -61,509	-7%	-$2.1M	0.11%	142
2016 Q1	$27.6M	Sell	938,487 -63,987	-6%	-$1.77M	0.1%	142
2015 Q4	$49.6M	Buy	1,002,474 +8,808	+0.9%	+$229K	0.17%	79
2015 Q3	$23.5M	Sell	993,666 -38,532	-4%	-$930K	0.08%	143
2015 Q2	$24.5M	Buy	1,032,198 +108,000	+12%	+$2.44M	0.07%	152
2015 Q1	$21.9M	Buy	924,198 +282,024	+44%	+$6.33M	0.06%	165
2014 Q4	$13.6M	Buy	642,174 +378,624	+144%	+$7.61M	0.03%	226
2014 Q3	$4.49M	Buy	263,550 +53,472	+25%	+$844K	0.01%	451
2014 Q2	$3.01M	Buy	210,078 +138,678	+194%	+$1.88M	0.01%	564
2014 Q1	$883K	Sell	71,400 -1,800	-2%	-$20.8K	﹤0.01%	490
2013 Q4	$796K	Hold	73,200	–	–	﹤0.01%	494
2013 Q3	$850K	Sell	73,200 -1,800	-2%	-$21.1K	﹤0.01%	464
2013 Q2	$840K	Buy	+75,000	New	+$888K	﹤0.01%	457

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Aberdeen Asset Management's EW Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Edwards Lifesciences (EW) stake by 5.5% in Q2 2017, selling an estimated $396K and leaving 186,024 shares worth $7.33M. The position accounts for 0.02% of the portfolio, ranked #407.

Aberdeen Asset Management first reported a position in EW in Q2 2013 and has held it in 17 quarters since. The position peaked at $49.6M in Q4 2015. 721 funds tracked by Wall St. Rank hold EW as of Q2 2017.

Aberdeen Asset Management held 186,024 shares of Edwards Lifesciences worth $7.33M as of Q2 2017.
Aberdeen Asset Management sold 10,857 Edwards Lifesciences shares in Q2 2017, an estimated $396K.
Edwards Lifesciences made up 0.02% of Aberdeen Asset Management's portfolio in Q2 2017, its #407 holding.
Aberdeen Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Edwards Lifesciences position peaked at $49.6M in Q4 2015.
721 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.